IL101087A - History of Imidazol-2-On-Transformed Preparation and Pharmaceutical Preparations Containing Them - Google Patents
History of Imidazol-2-On-Transformed Preparation and Pharmaceutical Preparations Containing ThemInfo
- Publication number
- IL101087A IL101087A IL10108792A IL10108792A IL101087A IL 101087 A IL101087 A IL 101087A IL 10108792 A IL10108792 A IL 10108792A IL 10108792 A IL10108792 A IL 10108792A IL 101087 A IL101087 A IL 101087A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- compound
- hydrogen
- alkyl
- azabicyclo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
- Cephalosporin Compounds (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919106571A GB9106571D0 (en) | 1991-03-27 | 1991-03-27 | Derivatives of substituted imidazol-2-one and process for their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
IL101087A0 IL101087A0 (en) | 1992-11-15 |
IL101087A true IL101087A (en) | 1996-01-31 |
Family
ID=10692325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10108792A IL101087A (en) | 1991-03-27 | 1992-02-27 | History of Imidazol-2-On-Transformed Preparation and Pharmaceutical Preparations Containing Them |
Country Status (21)
Country | Link |
---|---|
US (2) | US5242929A (fr) |
EP (1) | EP0505778B1 (fr) |
JP (1) | JP3315144B2 (fr) |
KR (1) | KR920018030A (fr) |
AT (1) | ATE128980T1 (fr) |
AU (1) | AU644720B2 (fr) |
CA (1) | CA2062271C (fr) |
DE (1) | DE69205312T2 (fr) |
DK (1) | DK0505778T3 (fr) |
ES (1) | ES2080975T3 (fr) |
FI (1) | FI921308A (fr) |
GB (1) | GB9106571D0 (fr) |
GR (1) | GR3018342T3 (fr) |
HU (1) | HU208135B (fr) |
IE (1) | IE76918B1 (fr) |
IL (1) | IL101087A (fr) |
MX (1) | MX9201279A (fr) |
MY (1) | MY108681A (fr) |
NZ (1) | NZ241785A (fr) |
RU (1) | RU2056418C1 (fr) |
TW (1) | TW198719B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9212486D0 (en) * | 1992-06-12 | 1992-07-22 | Erba Carlo Spa | Derivatives of substituted imidazo benzoxazin-1-one and process for their preparation |
SK94393A3 (en) * | 1992-09-11 | 1994-08-10 | Thomae Gmbh Dr K | Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those |
GB9224144D0 (en) * | 1992-11-18 | 1993-01-06 | Erba Carlo Spa | Phenyl-imidazolidinone derivatives and process for their preparation |
DE4332168A1 (de) * | 1993-02-22 | 1995-03-23 | Thomae Gmbh Dr K | Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
JP3916092B2 (ja) * | 1993-09-17 | 2007-05-16 | 杏林製薬株式会社 | イミダゾリジノン誘導体とその酸付加塩及び老年性痴呆症の治療薬 |
JP3916093B2 (ja) * | 1993-09-17 | 2007-05-16 | 杏林製薬株式会社 | 光学活性イミダゾリジノン誘導体とその製造方法 |
GB9410441D0 (en) * | 1994-05-25 | 1994-07-13 | Erba Carlo Spa | Azabicycloakyl derivatives of imidazo (1,5-a) indol-3-one and process for their preparation |
US6347538B1 (en) * | 2000-11-29 | 2002-02-19 | Gerald J. Doiron | Locking mechanism for weapons |
US6770655B2 (en) * | 2002-01-18 | 2004-08-03 | Aryx Therapeutics | 5-HT3 receptor antagonists and methods of use |
MA37975B2 (fr) | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
AU2021215396A1 (en) | 2020-02-03 | 2022-09-29 | Genzyme Corporation | Methods for treating neurological symptoms associated with lysosomal storage diseases |
US11857512B2 (en) | 2020-07-24 | 2024-01-02 | Genzyme Corporation | Pharmaceutical compositions comprising venglustat |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3702327A (en) * | 1970-12-28 | 1972-11-07 | Aldrich Chem Co Inc | N-beta-1-(3-phenylimidazolidin-2-one)ethyl 4,4-ethylene dioxypiperidines |
EP0235878A3 (fr) * | 1986-01-16 | 1989-06-14 | Beecham Group Plc | Nouveaux composés |
EP0255297B1 (fr) * | 1986-07-31 | 1993-04-21 | Beecham Group Plc | Composés azabicycliques, procédé pour leur préparation et leur utilisation pharmaceutique |
IE62231B1 (en) * | 1987-12-24 | 1995-01-11 | Wyeth John & Brother Ltd | Heterocyclic compounds |
IT1230881B (it) * | 1989-06-20 | 1991-11-08 | Angeli Inst Spa | Derivati del r(-) 3-chinuclidinolo |
DK443489D0 (da) * | 1989-09-08 | 1989-09-08 | Ferrosan As | Substituerede urinstofforbindelser, deres fremstilling og anvendelse |
GB8922622D0 (en) * | 1989-10-07 | 1989-11-22 | Wyeth John & Brother Ltd | Aroylureas |
-
1991
- 1991-03-27 GB GB919106571A patent/GB9106571D0/en active Pending
-
1992
- 1992-02-25 AU AU11214/92A patent/AU644720B2/en not_active Ceased
- 1992-02-27 IL IL10108792A patent/IL101087A/en not_active IP Right Cessation
- 1992-02-28 NZ NZ241785A patent/NZ241785A/en unknown
- 1992-02-28 US US07/843,339 patent/US5242929A/en not_active Expired - Lifetime
- 1992-03-04 CA CA002062271A patent/CA2062271C/fr not_active Expired - Fee Related
- 1992-03-05 AT AT92103724T patent/ATE128980T1/de active
- 1992-03-05 EP EP92103724A patent/EP0505778B1/fr not_active Expired - Lifetime
- 1992-03-05 DE DE69205312T patent/DE69205312T2/de not_active Expired - Fee Related
- 1992-03-05 ES ES92103724T patent/ES2080975T3/es not_active Expired - Lifetime
- 1992-03-05 DK DK92103724.8T patent/DK0505778T3/da active
- 1992-03-07 TW TW081101751A patent/TW198719B/zh active
- 1992-03-23 MY MYPI92000483A patent/MY108681A/en unknown
- 1992-03-23 MX MX9201279A patent/MX9201279A/es not_active IP Right Cessation
- 1992-03-25 FI FI921308A patent/FI921308A/fi unknown
- 1992-03-26 KR KR1019920004892A patent/KR920018030A/ko active IP Right Grant
- 1992-03-26 RU SU925011244A patent/RU2056418C1/ru active
- 1992-03-26 IE IE920961A patent/IE76918B1/en not_active IP Right Cessation
- 1992-03-26 HU HU9200946A patent/HU208135B/hu not_active IP Right Cessation
- 1992-03-27 JP JP07146692A patent/JP3315144B2/ja not_active Expired - Fee Related
-
1993
- 1993-06-14 US US08/076,153 patent/US5401750A/en not_active Expired - Fee Related
-
1995
- 1995-12-08 GR GR950403461T patent/GR3018342T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH0570457A (ja) | 1993-03-23 |
DK0505778T3 (da) | 1995-12-11 |
KR920018030A (ko) | 1992-10-21 |
CA2062271A1 (fr) | 1992-09-28 |
JP3315144B2 (ja) | 2002-08-19 |
GB9106571D0 (en) | 1991-05-15 |
CA2062271C (fr) | 2003-04-08 |
AU644720B2 (en) | 1993-12-16 |
ATE128980T1 (de) | 1995-10-15 |
HU208135B (en) | 1993-08-30 |
MY108681A (en) | 1996-10-31 |
FI921308A0 (fi) | 1992-03-25 |
IE76918B1 (en) | 1997-11-05 |
US5401750A (en) | 1995-03-28 |
TW198719B (fr) | 1993-01-21 |
HU9200946D0 (en) | 1992-05-28 |
US5242929A (en) | 1993-09-07 |
RU2056418C1 (ru) | 1996-03-20 |
FI921308A (fi) | 1992-09-28 |
GR3018342T3 (en) | 1996-03-31 |
MX9201279A (es) | 1992-10-01 |
HUT61021A (en) | 1992-11-30 |
EP0505778B1 (fr) | 1995-10-11 |
DE69205312T2 (de) | 1996-03-14 |
EP0505778A1 (fr) | 1992-09-30 |
NZ241785A (en) | 1994-01-26 |
ES2080975T3 (es) | 1996-02-16 |
IE920961A1 (en) | 1992-10-07 |
DE69205312D1 (de) | 1995-11-16 |
AU1121492A (en) | 1992-10-01 |
IL101087A0 (en) | 1992-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4789673A (en) | Heterocyclic carboxylic acid amides and esters | |
US4910207A (en) | Method of treating psychosis with N-quinuclidinyl-benzamides | |
CA2062271C (fr) | Derives de substitution d'imidazol-2-one et methode de preparation | |
US5362740A (en) | Dihydrobenzofuran carboxamides and process for their preparation | |
US5637596A (en) | Azabicycloalkyl derivatives of imidazo[1,5-a]indol-3-one and process for their preparation | |
US5364854A (en) | Derivatives of substituted imidazo benzoxazin-1-one and process for their preparation | |
EP0711296A1 (fr) | DERIVES IMIDAZOLYLALKYLES D'IMIDAZOL(5,1-c)(1,4)BENZOXAZIN-1-ONE ET LEUR UTILISATION COMME AGENTS THERAPEUTIQUES | |
US5424328A (en) | Phenyl-imidazolidinone derivatives | |
US5874457A (en) | Imidazolylalkyl derivatives of imidazo 1,5-a!indol-3-one |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
HC | Change of name of proprietor(s) | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |